Cardiac imaging to identify patients at risk for developing heart failure after myocardial infarction.

被引:12
作者
Azevedo C.F. [1 ]
Cheng S. [1 ]
Lima J.A. [1 ]
机构
[1] Division of Cardiology, Johns Hopkins University School of Medicine, Blalock 524, 600 N. Wolfe Street, Baltimore, 21287, MD
关键词
Cardiovascular Magnetic Resonance; Infarct Size; Leave Ventricular Remodel; Leave Ventricular Systolic Dysfunction; Microvascular Obstruction;
D O I
10.1007/BF02696648
中图分类号
学科分类号
摘要
The development of heart failure (HF) after acute myocardial infarction (MI) is recognized as a major complication that leads to a significant increase in morbidity and mortality. Given the availability of effective treatments for improving both quality of life and survival for patients at increased risk for developing HF after MI, early identification of these individuals is critical. Noninvasive cardiac imaging offers a detailed characterization of two important pathophysiological processes related to the development of HF post-MI: left ventricular (LV) remodeling and LV functional recovery. Cardiovascular MRI has recently emerged as the preferred noninvasive imaging modality because of its ability to provide the most comprehensive and informative evaluation of these processes. In addition to allowing for an accurate and reproducible longitudinal follow-up of LV volumes and mass, MRI also offers information on infarct size, the presence of microvascular obstruction, and the transmural extent of infarct scar, all of which are valuable parameters that can assist in identifying patients at risk for developing HF after MI.
引用
收藏
页码:183 / 188
页数:5
相关论文
共 150 条
[1]  
Spencer FA(1999)Twenty year trends (1975–1995) in the incidence, in-hospital and long-term death rates associated with heart failure complicating acute myocardial infarction: a community-wide perspective J Am Coll Cardiol 34 1378-1387
[2]  
Meyer TE(2002)Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2) J Am Coll Cardiol 40 1389-1394
[3]  
Goldberg RJ(1995)A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group N Engl J Med 333 1670-1676
[4]  
Wu AH(1998)Changes in absolute and relative importance in the prognostic value of left ventricular systolic function and congestive heart failure after acute myocardial infarction. TRACE Study Group. Trandolapril Cardiac Evaluation Am J Cardiol 81 1292-1297
[5]  
Parsons L(2001)Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial Lancet 357 1385-1390
[6]  
Every NR(1992)Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. The SAVE Investigators N Engl J Med 327 669-677
[7]  
Bates ER(1988)Cellular mechanisms of myocardial infarct expansion Circulation 78 186-201
[8]  
Kober L(1990)Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications Circulation 81 1161-1172
[9]  
Torp-Pedersen C(1981)Two-dimensional echocardiographic recognition of myocardial injury in man: comparison with postmortem studies Circulation 63 401-408
[10]  
Carlsen JE(1986)Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion Circulation 74 693-702